- Home
- WORX vs LIPO Comparison
WORX vs LIPO Comparison
Compare WORX & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WORX
- LIPO
- Stock Information
- Founded
- WORX N/A
- LIPO 2005
- Country
- WORX United States
- LIPO United States
- Employees
- WORX N/A
- LIPO N/A
- Industry
- WORX Services-Misc. Amusement & Recreation
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- WORX Consumer Discretionary
- LIPO Health Care
- Exchange
- WORX Nasdaq
- LIPO Nasdaq
- Market Cap
- WORX 3.4M
- LIPO 3.8M
- IPO Year
- WORX N/A
- LIPO 2022
- Fundamental
- Price
- WORX $1.37
- LIPO $2.55
- Analyst Decision
- WORX
- LIPO Strong Buy
- Analyst Count
- WORX 0
- LIPO 1
- Target Price
- WORX N/A
- LIPO $16.00
- AVG Volume (30 Days)
- WORX 37.4K
- LIPO 55.5K
- Earning Date
- WORX 11-14-2024
- LIPO 02-25-2025
- Dividend Yield
- WORX N/A
- LIPO N/A
- EPS Growth
- WORX N/A
- LIPO N/A
- EPS
- WORX N/A
- LIPO N/A
- Revenue
- WORX $3,224,146.00
- LIPO $483,533.00
- Revenue This Year
- WORX N/A
- LIPO N/A
- Revenue Next Year
- WORX N/A
- LIPO N/A
- P/E Ratio
- WORX N/A
- LIPO N/A
- Revenue Growth
- WORX N/A
- LIPO 0.78
- 52 Week Low
- WORX $0.75
- LIPO $2.21
- 52 Week High
- WORX $4.44
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- WORX 35.39
- LIPO 37.81
- Support Level
- WORX $1.73
- LIPO $2.60
- Resistance Level
- WORX $1.90
- LIPO $2.80
- Average True Range (ATR)
- WORX 0.12
- LIPO 0.15
- MACD
- WORX -0.04
- LIPO -0.03
- Stochastic Oscillator
- WORX 12.28
- LIPO 7.69
About WORX SCWorx Corp.
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.